Dow Up 1.31% Nasdaq Up 2.40%

CytRx Corporation (CYTR)

-NasdaqCM
2.76 0.03(1.10%) Oct 21, 4:00PM EDT
Prev Close:2.73
Open:2.72
Bid:2.20 x 200
Ask:4.96 x 300
1y Target Est:11.00
Beta:0.86
Next Earnings Date:N/A
Day's Range:2.66 - 2.87
52wk Range:2.00 - 8.35
Volume:712,150
Avg Vol (3m):828,405
Market Cap:153.87M
P/E (ttm):N/A
EPS (ttm):-1.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRUp 1.10%153.87M
LLY69.32B
NVS214.99B
SNY136.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,521.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback